John M. Pagel
-
- Chronic Lymphocytic Leukemia Research 18
-
- Lymphoma Diagnosis and Treatment 10
-
- Chronic Myeloid Leukemia Treatments 2
- Acute Myeloid Leukemia Research 1
-
- Immunodeficiency and Autoimmune Disorders 6
- T-cell and Retrovirus Studies 1
-
- Advanced Breast Cancer Therapies 2
-
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Nishitha ReddyJacob D. SoumeraiAdam S. AschAndrew D. ZelenetzDeepa JagadeeshVaishalee P. KenkreAnastasios StathisAnthony R. Mato
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)Blood (7 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
John M. Pagel
18 papers receiving 95 citations
Peers
Comparison fields: 5 of 21
- Genetics 77
- Pathology and Forensic Medicine 70
- Hematology 20
- Oncology 25
- Gastroenterology 5
Countries citing papers authored by John M. Pagel
This map shows the geographic impact of John M. Pagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Pagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Pagel more than expected).
Fields of papers citing papers by John M. Pagel
This network shows the impact of papers produced by John M. Pagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Pagel. The network helps show where John M. Pagel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John M. Pagel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 0 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 4 | |
| 14 | 2020 | 8 | |
| 15 | 2019 | 21 | |
| 16 | 2019 | 5 | |
| 17 | 2019 | 12 | |
| 18 | 2018 | 1 | |
| 19 | 2018 | 13 | |
| 20 | 2017 | 5 |
About John M. Pagel
John M. Pagel is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 20 papers that have together received 96 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (10 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Advanced Breast Cancer Therapies (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Acute Myeloid Leukemia Research (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Genetics (77 citations), Pathology and Forensic Medicine (70 citations) and Hematology (20 citations). John M. Pagel has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Nishitha Reddy, Jacob D. Soumerai, Adam S. Asch, Andrew D. Zelenetz, Deepa Jagadeesh, Vaishalee P. Kenkre, Anastasios Stathis, Anthony R. Mato, Neil A. Bailey and Haresh Jhangiani. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.